Randomized controlled trial of sirolimus conversion in cardiac transplant recipients with renal insufficiency

A. Zuckermann, Anne Keogh, M. G. Crespo-Leiro, D. Mancini, F. González Vilchez, L. Almenar, S. Brozena, H. Eisen, S. See Tai, S. Kushwaha

Research output: Contribution to journalArticlepeer-review

63 Scopus citations


This randomized, comparative, multinational phase 3b/4 study of patients 1-8 years postcardiac transplantation (mean 3.9 years) evaluated the effect of conversion from a calcineurin inhibitor (CNI) to sirolimus on renal function in patients with renal insufficiency. In total, 116 patients on CNI therapy with GFR 40-90 mL/min/1.73m2 were randomized (1:1) to sirolimus (n = 57) or CNI (n = 59). Intent-to-treat analysis showed the 1-year adjusted mean change from baseline in creatinine clearance (Cockcroft-Gault) was significantly higher with sirolimus versus CNI treatment (+3.0 vs. -1.4 mL/min/1.73 m 2, respectively; p = 0.004). By on-therapy analysis, values were +4.7 and -2.1, respectively (p < 0.001). Acute rejection (AR) rates were numerically higher in the sirolimus group; 1 AR with hemodynamic compromise occurred in each group. A significantly higher treatment discontinuation rate due to adverse events (AEs; 33.3% vs. 0%; p < 0.001) occurred in the sirolimus group. Most common treatment-emergent AEs significantly higher in the sirolimus group were diarrhea (28.1%), rash (28.1%) and infection (47.4%). Conversion to sirolimus from CNI therapy improved renal function in cardiac transplant recipients with renal impairment, but was associated with an attendant AR risk and higher discontinuation rate attributable to AEs. This randomized, comparative, multinational study of cardiac transplant recipients with mild to moderate renal insufficiency shows that conversion to sirolimus from calcineurin inhibitor therapy significantly improves renal function but with an attendant risk of acute rejection.

Original languageEnglish (US)
Pages (from-to)2487-2497
Number of pages11
JournalAmerican Journal of Transplantation
Issue number9
StatePublished - Sep 2012

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Transplantation
  • Pharmacology (medical)


Dive into the research topics of 'Randomized controlled trial of sirolimus conversion in cardiac transplant recipients with renal insufficiency'. Together they form a unique fingerprint.

Cite this